| EEMS Methods Study Work |
Erikka Loftfield |
National Cancer Institute |
PLCO |
Mar 18, 2020 |
2020-9001 |
| Aspirin use and risk of hepatocellular carcinoma incidence and mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
Holli Loomans-Kropp |
National Cancer Institute |
PLCO |
Mar 18, 2020 |
PLCO-601 |
| Dietary inflammatory potential and risk of liver cancer in the PLCO study |
Xuehong Zhang |
The Brigham and Women’s Hospital, Inc. |
PLCO |
Mar 16, 2020 |
PLCO-598 |
| A Machine Learning Approach to Bladder Cancer Screening and Cancer Grade/Stage Differentiation |
Herbert Chase |
The Trustees of Columbia University in the City of New York |
PLCO |
Mar 16, 2020 |
PLCO-597 |
| Association of colorectal polyps with dietary inflammation during screening colonoscopy in Men and Women |
Bhaumik Brahmbhatt |
Mayo Clinic |
PLCO |
Mar 16, 2020 |
PLCO-593 |
| Risk Prediction Model for Endometrial Cancer using multiple Machine Learning Algorithms and Meta-Analysis |
Denis Mihaies |
Brunel Univeristy |
PLCO |
Mar 16, 2020 |
PLCO-590 |
| Interpretable Artificial Intelligence to select patients that will benefit from lung cancer screening |
Jean-Emmanuel Bibault |
Stanford University |
PLCO |
Mar 5, 2020 |
PLCO-594 |
| Personalizing colorectal treatment strategies through machine learning |
Jean-Emmanuel Bibault |
Stanford University |
PLCO |
Feb 27, 2020 |
PLCO-592 |
| Treatment effect on the Survival Time of Lung Cancer Patients |
Jing Zhou |
Department of Family and Preventive Medicine |
PLCO |
Feb 27, 2020 |
PLCO-591 |
| Developing a metabolite-based biomarker panel for prostate cancer detection and prognosis in African-American men |
Arun Sreekumar |
Baylor College of medicine |
PLCO |
Feb 19, 2020 |
PLCO-583 |
| Second-hand smoke (SHS) and mortality in never-smoking women |
Neal Freedman |
NCI |
PLCO |
Feb 19, 2020 |
PLCO-586 |
| A new mathematical model for the computation of optimal screening frequencies for lung and colorectal cancer |
Johannes Reiter |
Stanford University |
PLCO |
Feb 7, 2020 |
PLCO-581 |
| Bayesian network in differential diagnosis of head and neck cancer |
Kamila Bukirova |
Near East University |
PLCO |
Feb 7, 2020 |
PLCO-571 |
| Evaluation of dietary methionine intake and breast cancer incidence |
Vincent Cryns |
University of Wisconsin Madison |
PLCO |
Feb 7, 2020 |
PLCO-579 |
| Personalizing Lung Cancer Screening for Smokers with Comorbidities |
Minal Kale |
Icahn School of Medicine at Mount Sinai |
PLCO |
Feb 7, 2020 |
PLCO-578 |
| A new method to estimate the predictive value in a screening program |
Jian-Lun Xu |
NCI |
PLCO |
Feb 7, 2020 |
PLCO-580 |
| Secondary analysis of association between ethnicity and endometriosis when adjusted for age at first pregnancy using data from the PCLO-dataset |
Frank Teunissen |
London School of Hygiene and Tropical Medicine |
PLCO |
Feb 3, 2020 |
PLCO-569 |
| Evaluating existing data on circulating inflammatory markers in relation to history of benign gynecologic pathology and history of oral contraceptive use. |
Lauren King |
NCI-DCEG |
PLCO |
Jan 30, 2020 |
PLCO-576 |
| Use of Tobacco Biomarkers in Lung Cancer Risk Assessment |
Christine Lambert |
University of Minnesota |
PLCO |
Jan 30, 2020 |
PLCO-563 |
| Prostate cancer risk prediction using clinical risk factors and genetics |
Nathan White |
Multimodal Imaging Services Corporation, dba HealthLytix |
PLCO |
Jan 30, 2020 |
PLCO-574 |
